Certified by Founder Lodge
5AM Ventures
United States - San Francisco, California
INVESTOR
1 Disclosed Funding Rounds $100,000,000
17 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
5AM was founded in 2002 and pursues investments in advanced life science innovations, and seeks to be diversified across the biopharmaceutical therapeutics, and platform technologies. Within
| Company | Date | Round | Raised |
|---|---|---|---|
 Karius |
May, 03 ,2024 | Series C | $100,000,000 |
| Karius |
May, 03 ,2024 | Series C | $100,000,000 |
 TMRW Life Sciences |
July, 25 ,2024 | Series D | $28,000,000 |
 CAMP4 Therapeutics |
July, 20 ,2022 | Series B | $100,000,000 |
 Renasant Bio |
July, 11 ,2025 | Seed | $54,500,000 |
 Ensoma |
February, 06 ,2023 | Series B | $85,000,000 |
 Fellow |
July, 16 ,2025 | Series B | $24,000,000 |
| TMRW Life Sciences |
July, 25 ,2024 | Series D | $28,000,000 |
 MapLight Therapeutics, Inc. |
October, 31 ,2023 | Series C | $225,000,000 |
| Renasant Bio |
July, 11 ,2025 | Seed | $54,500,000 |
 Radionetics Oncology |
January, 04 ,2024 | Series A | $52,500,000 |
 Latigo Biotherapeutics, Inc. |
February, 15 ,2024 | Series A | $135,000,000 |
| Karius |
May, 03 ,2024 | Series C | $100,000,000 |
| TMRW Life Sciences |
July, 25 ,2024 | Series D | $28,000,000 |
| Renasant Bio |
July, 11 ,2025 | Seed | $54,500,000 |
| Fellow |
July, 16 ,2025 | Series B | $24,000,000 |
 Kinaset Therapeutics |
January, 13 ,2026 | Series B | $103,000,000 |
Cherry Ventures
Blue Bear Capital
Slow Ventures
Climate Capital
Eniac Ventures
Allos | $5,000,000 | (Jan 14, 2026)
bricks.sh | $1,863,303 | (Jan 14, 2026)
JetZero | $175,000,000 | (Jan 14, 2026)
Converge Bio | $25,000,000 | (Jan 14, 2026)
Nodu | $1,450,000 | (Jan 14, 2026)
